HIM
LBPSW

HGC Investment Management’s 4D Pharma PLC Warrant LBPSW Stock Holding History

HGC Investment Management’s Portfolio LBPSW Stock Details LBPSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,072
Closed -$4K – 395
2021
Q3 		$4K Hold
5,072
– – ﹤0.01% 270
2021
Q2 		$6K Hold
5,072
– – ﹤0.01% 255
2021
Q1 		$6K Buy
+5,072
New +$6.35K ﹤0.01% 267

Other funds holding LBPSW

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HGC Investment Management's LBPSW Position: Q4 2021 in Review

HGC Investment Management sold out of 4D Pharma PLC Warrant (LBPSW) in Q4 2021, closing a stake of 5,072 shares — an estimated $4K sold.

HGC Investment Management first reported a position in LBPSW in Q1 2021 and held it in 3 quarters. The position peaked at $6K in Q2 2021. 5 funds tracked by Wall St. Rank hold LBPSW as of Q4 2021.

  • HGC Investment Management reported no remaining 4D Pharma PLC Warrant position as of Q4 2021 after selling out during the quarter.
  • HGC Investment Management sold 5,072 4D Pharma PLC Warrant shares in Q4 2021, an estimated $4K.
  • HGC Investment Management first reported a position in 4D Pharma PLC Warrant in Q1 2021 and held it in 3 quarters.
  • HGC Investment Management's 4D Pharma PLC Warrant position peaked at $6K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held 4D Pharma PLC Warrant as of Q4 2021.

Based on HGC Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.